Status:
UNKNOWN
Misoprostol for Cervical Priming Before Office Hysteroscopy
Lead Sponsor:
Kasr El Aini Hospital
Conditions:
Misoprostol Allergy
Eligibility:
FEMALE
19-45 years
Phase:
PHASE2
PHASE3
Brief Summary
The objective of the present study is to evaluate the appropriate route of administration of misoprostol, either oral or vaginal, for cervical priming to facilitate the procedure of office hysteroscop...
Detailed Description
Sample size calculation was done using the comparison of pain sensation represented through VAS between oral and vaginal misoprostol for cervical ripening before office hysteroscopy. As reported in pr...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Patients indicated for diagnostic hysteroscopy for infertility or AUB.
- Reproductive age \>19 - 45yrs.
- Postmenstrual between days 7 and 11 of the cycle ( except in irregular bleeding)
- Exclusion criteria:
- Contraindicating the use of prostaglandins such as:-
- Cardiovascular disease
- Severe bronchial asthma.
- Hypertension.
- Renal failure.
- Known sensitivity to Prostaglandins
- Contraindication to office hysteroscopy such as:-
- Pelvic inflammatory disease.
- Marked cervical stenosis.
- Known cervical malignancy.
- pregnancy
- profuse uterine bleeding
- Recent uterine perforation.
- Neurological disorders affecting the evaluation of pain.
- Previous cervical surgery.
Exclusion
Key Trial Info
Start Date :
October 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03276000
Start Date
October 1 2017
End Date
March 1 2018
Last Update
October 17 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kasr El Ainiy Hospital
Cairo, Egypt, 11562